Acne Treatment with Tretinoin (Retinoic Acid) and Copper Peptide

Factsheet Add comments

Retinoic Acid increases skin cell turnover, promoting mild peeling of the skin which unplugs whiteheads and blackheads. This acne medication is very efficient in exfoliating the skin and in the prevention of microcomedo formation. The downside of Tretinoin use is skin irritation which causes the skin to turn red, itchy and flaky. Increased sun sensitivity is also another problem with Tretinoin use. Using topical copper peptide together with retinoic acid, significantly reduce the side effects associated with retinoic acid use. Topical copper peptide also accelerates the skin repair mechanism and protects the skin from photodamage.

Materials:

0.025% Tretinoin Microspheres Cream (Stieva-A, Retin-A Micro)
Skin BiologyTM “super GHK serum” or Skin BiologyTM “super GHK cream” for sensitive skin
Skin BiologyTM “CP Serum” for normal skin

Procedure:

1. Remove oil and dirt from the face using soap and water then pat dry your face with a clean towel.
2. Apply Tretinoin Microspheres cream on affected areas and allow this acne medication to be absorbed on the skin for at least one hour (the longer the better).
3. Wash away the tretinoin microspheres gel using only tap water then pat dry your face with a clean towel.
4. Apply topical copper peptide on affected areas and leave it overnight on the face.

Notes:

Precautions:

Consult your doctor first if you are pregnant, lactating or could become pregnant during the use of this type of acne treatment. This acne medication is not intended to be used on children.

References:

1. http://www.skinbiology.com “Published Studies on Tissue and Skin Remodeling Copper-Peptides ” by Loren Pickart PhD (April 2003)
2. http://www.copper.org/innovations/2006/06/copper_your_skin.html “Copper and Your Skin: Facelift In A Bottle By William H. Dresher, Ph.D., P.E ( June 2006 ).
3. Aditya K Gupta MD, PhD, FRCP(C), Melissa D Gover BSc, William Abramovits MD (2007) Ziana (Clindamycin Phosphate 1.2% and Tretinoin 0.025%)Gel SKINmed 6 (2), 85–87.
4. Tretinoin: A review of preclinical toxicological studies Marvin Cohen * Scientific Information Services Department, Hoffmann-LaRoche, Inc., Nutley, New Jersey
5. http://www.retinamicro.com

Last update: December 31, 2008

Leave a Reply

WP Theme & Icons by N.Design Studio. Modified by Terry Labunda
Entries RSS Comments RSS Log in